AstraZeneca is to raise $3.5 billion to fund a global development and marketing collaboration with Daiichi Sankyo, for an antibody-drug conjugate and potential new targeted cancer medicine, ...
Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
Switch to solar with a system built for you. Solar panels can lower your electricity bill by 75% or more, but the upfront investment is significant. Most homeowners spend between $12,600 and $33,376 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results